RÉSUMÉ
Background: A parasitic hydatid disease called liver echinococcosis is brought on by the tapeworm echinococcus and is a reason for concern for global health. In addition to the liver, the lungs can harbor parasites. In the life cycle of parasites, humans occupy a middle position. Depending on the size and intensity of the cyst, the clinical signs can vary and be non-specific. The complications include bleeding, perforation, suppuration, cyst rupture, mechanical jaundice, and portal hypertension. Here is an analysis of own results of surgical treatment of patients with liver echinococcosis in Grodno region, Belarus between June 2012 to October 2022. Methods: The research design was cross-sectional. Diagnostic methods that are instrumental and laboratory-based include a general blood test, a biochemical blood test, an enzyme immunoassay (IFA), abdominal and retroperitoneal MRIs and ultrasounds, abdominal and chest CT scans and brain scans. There were 10 men and 17 women among the 27 patients. The age range of the majority of the patients was 18 to 83. Results: All patients underwent resections, including laparoscopic procedures. One of the patients in our series of cases received a two-stage therapy regimen due to a secondary focus of echinococcosis in the left lung. In our series of cases, no postoperative complications or mortality occurred. Conclusions: Patients with hepatic echinococcosis should be treated at specialized hospitals. Abdominal, chest, and brain CT scans are required in order to search for additional foci. When it comes to treating echinococcosis, minimal invasive surgical procedures should be preferred.